Article
Corrected: A Prognostic Necroptosis-Related lncRNA Signature to Predict the Immune Response and Drug Sensitivity of Bladder Cancer
2022-04-07
Abstract excerpt
<h4>Background: </h4> Patients with bladder cancer (BLCA), especially those with advanced stage cancer, have a short life span; thus, new drugs need to be developed urgently to improve the situation. Long noncoding RNAs (lncRNAs) are considered regulatory targets for cancer, including BLCA. Therefore, we constructed a promising signature of lncRNAs related to necroptosis and further predicted the immune response a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 514ae00d-86a3-5134-9c5d-242d9a54e1ea
- DOI
- 10.21203/rs.3.rs-1530906/v1
